Influence of diastereomeric ratios of deoxyribonucleoside phosphoramidites on the synthesis of phosphorothioate oligonucleotides

Nucleosides, Nucleotides and Nucleic Acids

Volumn 19, Issue 3, 2000, Pages 533-543

  Cheruvallath, Z S ^a   Sasmor, H ^a   Cole, D L ^a   Ravikumar, V T ^a  

^a ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

ANALYTIC METHOD; ARTICLE; CHIRALITY; DRUG SYNTHESIS; GEL CHROMATOGRAPHY; GENE EXPRESSION REGULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; OLIGOMERIZATION; REPRODUCIBILITY; SOLID PHASE EXTRACTION; STEREOISOMERISM;

EID: 0033999899     PISSN: 15257770     EISSN: None     Source Type: Journal    
DOI: 10.1080/15257770008035005     Document Type: Article

References (36)

1. Crooke, S.T. (1995) in Burger's Medicinal Chemistry and Drug Discovery, Vol. 1 (Ed.: Wolff, M.E.), Wiley, pp. 863-900 and references cited therein.
2. Crooke, S.T. (1994) in Progress in Oligonucleotide Therapeutics, American Society for Pharmacology and Experimental Therapeutics, Spring Meeting, April 24-28, Anaheim, CA, USA.
3. Crooke, S.T. (1995) in Therapeutic Applications of Oligonucleotides, (Ed.: Crooke, S.T.), R.G. Landes Co., and references cited therein.
4. Knorre, G. K.; Vlassov, V. V.; Zarytova, V. F.; Lebedev, A. V.; Federova, O. S. (1994) in Design and Targeted Reactions of Oligonucleotide Derivatives; (Eds.: Knorre, G. K.; Vlassov, V. V.; Zarytova, V. F.; Lebedev, A. V.; Federova, O. S.), CRC Press: Boca Raton, FL, USA.
5. Kisner, D. L. 12th International Roundtable on Nucleosides and Nucleotides, September 19, 1996, La Jolla, CA, USA.
6. Crooke, S. T.; Grillone, L. R.; Tendolkar, A.; Garrett, A.; Fraktin, M. J.; Leeds, J.; Barr, W. H. (1994) Biochem. Pharmacol., 56, 641-646.
7. Agrawal, S.; Zhang, X.; Lu, Z.; Zhao, H.; Tamburin, J. M.; Yan, J.; Cai, H.; Diasio, R. B.; Habus, I.; Jiang, Z.; Iyer, R. P.; Yu, D.; Zhang, R. (1995) Biochem. Pharmacol., 50, 571-576.
8. Varma, R. S. (1993) SYNLETT, 621-637.
9. Sanghvi, Y.S. in Comprehensive Natural Products Chemistry, (1997), (Eds.: Barton, D.H.R.; Nakanishi, K.) in Volume 7: DNA and Aspects of Molecular Biology, (Ed. Kool, E.T.) Pergamon Press, in press.
10. Liang, C., Allen, L.C. (1987) J. Am. Chem. Soc., 109, 6449-6453.
11. Several oligodeoxyribonucleotide phosphorothioates are in clinical trials e.g. ISIS 2922 has completed Phase III trials, an NDA was submitted and got approval for marketing from FDA in 1998, ISIS 2302, ISIS 3521, ISIS 5132 and ISIS 2503 are in Phase II stages, and several are in Phase I trials. In all about 20 drugs are being evaluated against various disease targets.
12. Beaucage, S.L., Caruthers, M.H. (1981) Tetrahedron Lett., 22, 1859-1862
13. McBride, L.J., Caruthers, M.H. (1983) Tetrahedron Lett., 24, 245-248.
14. Caruthers, M.H. (1985) Science, 230, 281.
15. Beaucage, S.L., Iyer, R.P. (1992) Tetrahedron, 48, 2223-2311.
16. Beaucage, S.L., Iyer, R.P. (1993) Tetrahedron, 49, 6123-6194.
17. Iyer, R.P., Egan, W., Regan, J.B., Beaucage, S.L. (1990) J. Am. Chem. Soc., 112, 1253-1254.
18. Iyer, R.P., Philips, L.R., Egan, W., Regan, J.B., Beaucage, S.L. (1990) J. Org. Chem., 55, 4693-4699.
19. Sinha, N. D.; Biernat, J.; Köster, H. (1983) Tetrahedron Lett., 24, 5843-5846.
20. Lyttle, M. H.; Wright, P. B.; Sinha, N. D.; Bain, J. D.; Chamberlin, A. R. (1991) J. Org. Chem., 56, 4608-4615.
21. Scozzari, A.N. Large Scale Oligonucleotide Synthesis : Production, Purification and Analysis, October 28-29, 1997, San Diego, CA, USA.
22. Stec, W.J., Grajkowski, A., Koziolkiewicz, M., Uznanski, B. (1991) Nucleic Acids Res., 19, 5883-5888.
23. Stec, W.J., Wilk, A. (1994) Angew. Chem. Int. Ed. Engl., 33, 709-722.
24. Wilk, A., Stec, W.J. (1995) Nucleic Acids Res., 23, 530-534.
25. Stec, W.J., Grajkowski, A., Kobylanska, A., Karwowski, B., Koziolkiewicz, M., Misiura, K., Okruszek, A., Wilk, A., Guga, P., Boczkowska, M. (1995) J. Am. Chem. Soc., 117, 12019.
26. Lesnikowski, Z.J. (1993) Bioorg. Chem., 21, 127-155.
27. Wyrzykiewicz, T.K., Cole, D.L. (1995) Bioorg. Chem., 23, 33-41.
28. Iyer, R.P., Yu, D., Ho, N., Tan, W., Agrawal, S. (1995) Tetrahedron: Asymmetry, 6, 1051-1054.
29. Charubala, R., Stengele, K.P., Pfleiderer, W. (1989) Nucleosides Nucleotides, 8, 1007-1010.
30. Stec, W.J., Zon, G. (1984) Tetrahedron Lett., 25, 5279-5282.
31. Stec, W.J., Zon, G., Gallo, K.A., Byrd, R.A. (1985) Tetrahedron Lett., 26, 2191-2194.
32. Stec, W.J., Zon, G. (1984) Tetrahedron Lett., 25, 5279-5282.
33. Wilk, A., Uznanski, B., Stec, W.J. (1991) Nucleic Acids Symp. Ser., 24, 63-66.
34. Berner, S., Mühlegger, K., Seliger, H. (1989) Nucleic Acids Res., 17, 853-864.
35. Dahl, B.H., Nielsen, J., Dahl, O. (1987) Nucleic Acids Res., 15, 1730-1743.
36. Ghosh, M., Ghosh, K., Cohen, J.S. (1992) Antisense Res. Dev. 2, 11.